In the News
Diversity In Clinical Trials Drives Better Patient Outcomes
The authors explore the latest draft guidance and review industry best practices to increase diversity in clinical trials.
Two Key Questions About Patient Experience in 2022
Soren Skovlund outlines what it takes to be a patient-first organization and how companies can better ensure they are delivering experiences that meet patients’ expectations.
PPD releases R&D trends in pharma and biotech report
Respondents to survey say the top challenge drug developers are currently facing is patient recruitment.
Robust Bioanalytical Studies Can Aid in Regulatory Submissions
Amy Lavelle discusses the challenges of performing bioanalytical studies and how CROs can help mitigate possible regulatory submission problems.
Sponsors already heeding FDA’s call for diversity planning, experts say
Rose Blackburne comments on the FDA’s guidance on trial diversity planning.
Chief Learning Officer reveals 2022 LearningElite award winners
The PPD clinical research business of Thermo Fisher Scientific was named a 2022 LearningElite silver award winner for its exemplary workforce development strategies that deliver significant business results.
Positioning the patient in drug trials
The authors discuss how the clinical research industry must integrate feedback from patients and sites to eliminate unnecessary burden and accelerate enrollment in clinical trials.
When is it appropriate to outsource bioanalysis work to a CRO?
Amy Lavelle and Laura Brunner discuss the factors to assess, such as type of work, regulatory considerations and the study’s needs.
CRO market insights
Company thought leaders discuss the impact of COVID and regulatory frameworks for clinical trials today.
